Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d₂

Cat. No.: HY-W098127S: FAQs
Fiche technique Instruction de manipulation

Molarity Calculator

Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d₂ is the deuterium labeled Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate[1].

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d<sub>2</sub> Chemical Structure

Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d₂ Chemical Structure

CAS No. : 1346597-78-1

Size		Stock
2.5 mg		Check price and availability
25 mg		Check price and availability

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Recommandations en vedette

•Related Small Molecules:

•Related Proteins:

Activité biologique
Pureté et documentation
Références
Avis client

Description	Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d₂ is the deuterium labeled Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate[1].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d₂ Related Antibodies
Masse moléculaire	255.22
Formule	C₁₁H₇D₂F₂N₃O₂
CAS No.	1346597-78-1
SMILES	FC(C=CC=C1F)=C1C([2H])([2H])N2C=C(N=N2)C(OC)=O
Livraison	Room temperature in continental US; may vary elsewhere.
Stockage	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation	Fiche technique (269 KB) Instruction de manipulation (2659 KB)
Références	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]